Luo Ying

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Gyre Therapeutics, Inc. (GYRE)

Transaction date 6 May 2026

Planned sale

Price

362.15

Quantity 18,972 +47.6%

Value US$1,048,364

Comments Filing

Gyre Therapeutics, Inc. (GYRE)

Transaction date 5 May 2026

Planned sale

Price

402.73

Quantity 70,598 +37.2%

Value US$3,512,294

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2026-05-07	2026-05-06	Gyre Therapeutics, Inc. (GYRE)	PlS Planned sale	18,972 +47.6% 362.15 US$1,048,364	18,972 +47.6%	362.15	US$1,048,364
2026-05-07	2026-05-05	Gyre Therapeutics, Inc. (GYRE)	PlS Planned sale	70,598 +37.2% 402.73 US$3,512,294	70,598 +37.2%	402.73	US$3,512,294